Dallas, TX, United States of America

Jing Li

This inventor holds 11 USPTO granted patents and 1 EPO patent. Top assignees: Cumbre Pharmaceuticals Inc., The University of Texas System. Active years: 2006-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Li. Retrieved from https://idiyas.com/inventor/jing-li-h9twg63a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 54.5


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Dallas, TX (US) (2006 - 2009)
  • San Antonio, TX (US) (2016 - 2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations of Inventor Jing Li

Introduction

Jing Li is a prominent inventor based in Dallas, TX (US), known for her significant contributions to the field of pharmaceuticals. With a total of 11 patents to her name, she has made remarkable strides in developing innovative solutions for medical applications.

Latest Patents

Among her latest inventions are the Taccalonolide microtubule stabilizers. This invention provides epoxytaccalonolide microtubule stabilizers and their use as anti-proliferative microtubule stabilizing agents. These advancements hold promise for enhancing treatment options in cancer therapy.

Career Highlights

Jing Li has worked with notable organizations such as Cumbre Pharmaceuticals Inc. and the University of Texas System. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Zhenkun Ma and Charles Z Ding. Their collaborative efforts have further enriched her research and development endeavors.

Conclusion

Jing Li's innovative work in the field of pharmaceuticals, particularly with her Taccalonolide microtubule stabilizers, showcases her dedication to advancing medical science. Her contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…